The FDA Calls Kyowa Hakko Kirin's Lymphoma Drug a Breakthrough Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR… Source: BioSpace You Might Also Like This Drug Could be the Most Crucial in Regeneron's Massive Pipeline August 22, 2017 FDA Stuns Celgene With Refusal to File Letter for MS Treatment Ozanimod February 27, 2018 Top 9 Biotech Giants to Work for in New Jersey July 5, 2017
